1-((1-(Fluoromethyl)cyclopropyl)methyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole

Catalog No. :
ACVSWB805
CAS No. :
2922723-18-8
Molecular Formula :
C14H22BFN2O2
Molecular Weight :
280.15

IUPAC Name:1-((1-(fluoromethyl)cyclopropyl)methyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole

1-((1-(Fluoromethyl)cyclopropyl)methyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$1821.00Login to see priceInquiryInquiry
1g98%$3606.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-((1-(Fluoromethyl)cyclopropyl)methyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
IUPAC Name1-((1-(fluoromethyl)cyclopropyl)methyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
Molecular FormulaC14H22BFN2O2
Molecular Weight280.15
SMILESCC1(C)C(C)(C)OB(C2=CN(CC3(CF)CC3)N=C2)O1
InChI KeyACNGWGAELREIGN-UHFFFAOYSA-N
Synonym1H-Pyrazole, 1-[[1-(fluoromethyl)cyclopropyl]methyl]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-;1-((1-(Fluoromethyl)cyclopropyl)methyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
CAS No.2922723-18-8

Synthetic Route by SureRoute

1. ACVSWB805 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACYUSO179 route compound structure diagram
    ACYUSO179269410-08-4 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVSWB805 route product structure diagram
    ACVSWB8052922723-18-8
Inquiry

2. ACVSWB805 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACYUSO179 route compound structure diagram
    ACYUSO179269410-08-4 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVSWB805 route product structure diagram
    ACVSWB8052922723-18-8
Inquiry

Comments (0)